Delivery Order SPE2DB20D3101-SPE2DB21FH8M0
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for $1,433.28 to provide pharmaceutical and medical supplies as a prime vendor to the Defense Logistics Agency (DLA). The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products, including...
- This federal contract award is for a prime vendor pharmaceutical supply contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00, and runs through December 2025. This Indefinite Delivery Contract (IDC) serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications,...
- This federal contract award is for a prime vendor pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. This Indefinite Delivery Contract (IDC) enables Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs,...
- This federal contract award is for a prime vendor pharmaceutical distribution contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $1,664.49, was awarded by the Defense Logistics Agency (DLA) to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999 and running through November 2026,...
- This federal contract award is for a prime vendor pharmaceutical program managed by the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $1,686.72 delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This IDC, which runs through November 2026, serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products...
- This federal contract award is for pharmaceutical and medical supply distribution services provided by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The award, valued at $1,156.08, was issued by the Defense Logistics Agency (DLA) under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,872.00 for pharmaceutical products and medical supplies. The contract was awarded by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order issued by the Defense Logistics Agency (DLA) for pharmaceutical and medical supplies. The contract is a Firm Fixed Price Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of essential medical commodities, including specialty medications,...
- This federal contract award is for a Prime Vendor Pharmaceutical contract held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $1,386.15, was awarded by the Defense Logistics Agency (DLA) and is for the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract is a Delivery Order under an Indefinite Delivery Contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for a Prime Vendor Pharmaceutical contract with the Defense Logistics Agency (DLA) valued at $7,181.84. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB21FH8M0Delivery Order
This federal contract award is for a prime vendor pharmaceutical contract valued at $1,829.75, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 2/22/21 |